Search

everythinglearnresearchcommunity

for

Search:↓

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

Polygonum multiflorum can promote hair growth when taken orally or applied topically.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

The document concludes that understanding dermal papilla cells is key to improving hair regeneration treatments.

Researchers developed a reliable method to measure testosterone and epitestosterone in urine for medical and anti-doping use.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Finasteride exposure harms tadpole reproduction and hormone balance.

Obesity is linked to various skin disorders, which can help with early diagnosis and prevention of long-term health issues.

Post-finasteride patients show changes in gut bacteria, possibly causing various symptoms.

Researchers developed a nanomedicine for acne treatment that delivers medication with less irritation and is non-irritating for oily skin.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

The photolyase-based device significantly changed the size and heat of potential skin cancer areas in patients.

Finasteride may cause lasting sexual, mental, and physical symptoms; use with caution.

The article concludes that global standardization in PCOS research is crucial for accurate diagnosis and understanding of the condition.

Finasteride reduces movement issues in Parkinson's disease rats.

Liquorice may reduce testosterone and affect male reproductive organs, potentially helping treat conditions like prostate cancer.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Spironolactone might cause painful intercourse and decreased sexual arousal in women.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

Post-finasteride syndrome causes sexual, physical, and psychological symptoms, but more research is needed to understand its causes and connection to finasteride.